|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Lebanon Pharmaceuticals and Healthcare Report Q3 2009
|
|
- Executive Summary
- SWOT Analysis
- Lebanon Pharmaceuticals And Healthcare Industry SWOT
- Lebanon Political SWOT
- Lebanon Economic SWOT
- Lebanon Business Environment SWOT
- Pharmaceutical Business Environment Ratings
- Table: Regional Pharma Business Environment Ratings For Q309
- Limits of Potential Returns
- Risks to Realisation of Returns
- Lebanon - Market Summary
- Regulatory Regime
- Public Sector Procurement
- Intellectual Property Regime
- IP Shortcomings
- Parallel Imports
- Counterfeit Drugs
- Free Trade Agreements
- Pricing and Reimbursement Issues
- Industry Developments
- Epidemiology
- HIV/AIDS Infections
- Healthcare Sector
- Hospital Sector
- Healthcare Insurance
- Healthcare Sector Reforms
- Regional Developments
- Pharmaceuticals Sector
- Recent Pharmaceutical Industry Developments
- Research and Development
- Medical Devices
- Industry Forecast Scenario
- Overall Market Forecasts
- Table: Lebanon - Drug Expenditure Indicators, 2003-2013
- Key Growth Factors - Industry
- Table: Lebanon - Health Expenditure, 2003-2013
- Key Growth Factors - Macroeconomic
- Table: Lebanon - Economic Activity, 2006 - 2013
- Prescription Market Forecast
- Table: Lebanon - Prescription Market Indicators, 2006-2013 (LBPmn unless otherwise indicated)
- OTC Market Forecast
- Table: Lebanon - OTC Market Indicators, 2003-2013 (LBPmn unless otherwise indicated)
- Patented Drug Market Forecast
- Patented Drug Market Forecast
- Table: Lebanon - Patented Market Indicators, 2003-2013
- Generics Market Forecast
- Table: Lebanon - Generics Market Indicators, 2003-2013
- Pharmaceutical Export/Import Market Forecasts
- Table: Lebanon - Pharmaceutical Export/Import Indicators, 2003-2013 (US$mn)
- Other Healthcare Data Forecasts
- Table: Lebanon - Other Healthcare Data, 2003-2013
- Key Risks to BMI Forecasts
- Competitive Landscape
- Company Profiles
- Multinational Companies
- Pfizer
- Novartis
- Merck & Co
- Johnson & Johnson
- Sanofi-Aventis
- Abbott Laboratories
- Indigenous Companies
- Chalhoub Pharmaceuticals (CHAPHA)
- Alfa Laboratories
- Algorithm
- Codipha
- Country Snapshot: Lebanon Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Section 2: Education and Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- BMI Forecast Modelling
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Snapshots Poland Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Venezuela Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Spain Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots South Africa Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Hungary Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
|
|
|
|
0 items
